Fruit of Mangosteen (Garcinia mangostana L.) is well-known in Indonesia and other Southeast Asian countries. Studies have shown that extract of the pericarp of mangosteen contained mostly of xanthones exhibit many biological activities, especially as an antitumor. This study aimed to investigate the cytotoxic activity and selectivity of Mangosteen Peel Extract (MPE) and α-mangostin against two leukemia cell lines (HL-60 and K-562) and the normal lymphocyte cells from two different donors. The cytotoxic activity was performed using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay. Imatinib and Isotretinoin were used as a positive control to the K-562 and HL-60 cells, respectively. The MPE and α-mangostin revealed higher mortality toward leukemia cell lines rather than toward lymphocyte cells, with more than 80% of HL-60 and K-562 cells died at 6.25 and 25 µg/ml, respectively. MPE was more toxic and selective against K-562 with IC50 of 2.79 µg/ml and SI of 8.27, while α-mangostin was more toxic and selective against HL-60 with IC50 of 1.12 µg/ml and SI of 22.34. MPE and α-mangostin showed potent sensitivity and selectivity to leukemia cells, hence these are considered as promising sources for future leukemia treatment.
Introduction
Cancer has been the second cause of death after cardiovascular diseases in the world. There were around 8.2 million of people died because of cancer and about 14.1 million of new cancer cases were detected in 2012 1 . Particularly in Indonesia, there was about 0.1% of total people suffering from cancer with 74.6% of mortality rate in male and 63.3% in female 2 . Lung or bronchus cancer, prostate cancer in men, breast cancer in the female, and colon or rectum cancer reveal as the most deadly cancer worldwide. However, rare cancer such as leukemia is also a cause of death because of its destructive nature 3 . According to the GLOBACAN, the percentage of leukemia was 2.5% of total new cases, contributing to 3.2% of total deaths by cancer in 2012 1 which was mostly suffered by children 4 .
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Characterized by high numbers of abnormal white blood cells, leukemia has been grouped into lymphoblastic and myeloid leukemia, namely Chronic Lymphocytic Leukemia (CLL) or Acute Lymphocytic Leukemia (ALL) and Chronic Myelogenous Leukemia (CML) or acute Myelogenous Leukemia (AML). Leukemia can be treated using interferon-α (IFN-α), Stem Cell Transplantation (SCT), radiotherapy and chemotherapy. Imatinib, a chemotherapy agent of tyrosine-kinase inhibitor, has been used as the first-line treatment for CML. It induces apoptosis and inhibition of proliferation by inhibiting the phosphorylation and binding process of Bcr-Abl oncoprotein 5 . Another chemotherapy agent for leukemia is retinoic acid, vitamin A derivative such as All-Trans Retinoic Acid (ATRA) and isotretinoin. They are used for several cancer treatment and remission including for Acute Promyelocytic Leukemia (APL), a subtype of AML by inducing cell apoptosis 6 . However, the usage of imatinib and retinoic acid as well as the other chemotherapy agents can generate side effects by damaging the normal cells and lead to the development of the multidrug resistance cancer 7 . Therefore, the finding of the safe, selective, and sensitive chemicals that have anticancer property is still needed.
Mangosteen (Garcinia mangostana L.) has been used as a traditional medicine to treat diseases related to immune and gastrointestinal for decades. Its extract contains several active compounds, including terpenes, anthocyanins, tannins, phenols, and xanthones 8 . Xanthones have been shown to have several pharmacological properties, including as an antitumor 9 . The most abundant and the most studied xanthones are α-mangostin, β-mangostin, γ-mangostin, garcinone E, and gartanin, and those xanthones possess great biological activities such as anti-allergy, anti-inflammatory, antioxidant, anti-tumor, antibacterial, antifungal and antiviral activities, neuroprotective, cardioprotective, and immunomodulation [10] [11] [12] . Prior studies revealed that α-mangostin were the most abundance xanthone derivative from the aqueous, acetone and methanol extract of mangosteen 9, 13 . Therefore, this study aimed to investigate the cytotoxic activity and selectivity of Mangosteen Peel Extract (MPE) and α-mangostin against two leukemia cell lines (HL-60 and K-562) and the normal lymphocyte cell from two different donors. The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium MTS) assay was used to investigate the cytotoxic effect of the MPE, α-mangostin, imatinib, and isotretinoin. Those data are used to reveal the IC 50 and Selectivity Index (SI) of the MPE and three other compounds to the HL-60 and K-562 cell lines. The in vitro result demonstrates that MPE and α-mangostin have a potential to use against leukemia by showing the higher cytotoxic effect and selective index to leukemia rather than the imatinib and isotretinoin.
Materials and Methods

Mangosteen Peel Extract (MPE) Preparation
The peels of Garcinia mangostana L. 
Leukimia Cell Lines Cultivation
Two different leukemia cell lines, human acute promyelocytic (HL-60) and human chronic myelogenous (K-562) were obtained from Stem Cells and Cancer Institute (SCI) Jakarta, Indonesia. Cell lines were cultured in supplemented Iscove's Modified Dulbecco's Medium (IMDM) (Biowest, France), 2% Penicillin-Streptomycin (Biowest, France), 10% Fetal Bovine Serum (FBS) (Biowest, France) and were incubated at 37°C in a humidified incubator with 5% CO 2 . After 24 hours of incubation, the number of viable cells was counted using a haemocytometer with tryphan blue staining to obtain a sufficient cell number for the cytotoxic assay.
Lymphocyte Isolation and Cultivation
Lymphocyte isolation from two the lymphocyte from other leukocytes histopaque (SigmaAldrich, U.S.A.) was added into the whole blood. Whole blood then was centrifuged at 1,800 rpm for 5 minutes to obtain the blood buffy coat. The blood buffy coat was added with 1x Phosphate Buffer Saline (PBS) (Biowest, France) and was centrifuged at 1,800 rpm for 10 minutes in 4 o C. Then, the pellet was added with 1x PBS and was centrifuged at 1,500 rpm for 10 minutes in 4 o C. The final pellet contained leukocytes was maintained in Roswell Park Memorial Institute Medium (RPMI) (Biowest, France) and supplemented with 1% non-essential amino acids, 1% 1-glutamine, 100 U/ml penicillin, 10mg/mL streptomycin and 10% heat-inactivated fetal calf serum (Biowest, France) then incubated at 37 o C in humidified air containing 5% CO 2 14 .
Cytotoxic Assay
Approximately 100 µL of lymphocyte, HL-60 and K-562 cell suspension contained 10 5 cells/ml were seeded in each well of 96-well plate. Following that, 100 µL of Isotretinoin (Roche, Switzerland) in different levels (100, 85, 70, 55, 40, and 25 µM) were added into the wells of lymphocyte and HL-60. Imatinib (Glivec, Novartis) in different levels (100, 50, 25, 12.5, 6.25, and 3.125 µM) were added into the wells of lymphocyte and K-562. α-mangostin (Cengdu Biopurify Phytochemical, China) (100, 50, 25, 12.5, 6.25, and 3.125 µM) and Mangosteen Peel Extract (MPE) (100, 50, 25, 12.5, 6.25, and 3.125 µg/mL) were added into the wells of lymphocytes, HL-60, and K-562. Cells then incubated at 37°C with 5% of CO 2 for 24 hours. Then, 20 µL of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxyme-thoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) (Promega, U.S.A.) was added into each well and plate was incubated at 5% CO 2 , 37ºC for 3 hours. Finally, the absorbance used to calculate the percentage of cell mortality (Equation 1) was measured at 490 nm with Multiskan GO (Thermo Scientific, U.S.A). Wells of each cell that not supplemented with the compounds were presented as the negative control. 
Selectivity Analysis
The Selectivity Index (SI) describes the selectivity of the MPE, α-mangostin, imatinib, and isotretinoin toward the leukemic cell lines. The index was calculated from IC 50 ratio of the lymphocytes and the cancerous cell line (HL-60 or K-562) (Equation 2) 15 . The compound with SI higher than 3 revealed a high selective compound against the HL-60 or K-562, and the opposite was a less selective compound. 
Statistical Analysis
All treatment in this study was done independently and conducted in triplicate. SPSS Statistic 17.0 for Windows was used to calculate the IC 50 of the compounds and the significant differences using probit analysis and one-way ANOVA, respectively. The mortality and viability data were presented as mean ± Standard Deviation (SD).
Results
Cytotoxic Effect of Each Compound
toward HL-60, K-562, and Leukocyte Table 1 to 4 show the cytotoxic effect of imatinib, isotretinoin, α-mangosteen and MPE presented as the percentage mortality of HL-60, K-562, and leukocyte. Isotretinoin and α-mangostin started at the concentration of 25 μM had more than 50% mortality to HL-60 and K-562, respectively. Imatinib and α-mangostin started at 12.5 μM showed more than 50% mortality to K-562 and HL-60, respectively (Table 1-3) . Those of MPE started at 3.125 µg/ml and at 6.25 µg/ml revealed more than 50% mortality to HL-60 and K-562, respectively (Table 4) . Furthermore, Figure 1 shows HL-60 and K-562 cell lines have lower density in a higher concentration of MPE and α-mangostin treatments.
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Sensitivity and Selectivity of Each Compound toward HL-60, K-562, and Leukocyte
Further analysis of percentage mortality of the compounds using probit regression revealed that the IC 50 of imatinib, isotretinoin, MPE, and α-mangostin were high to normal lymphocyte and the IC 50 MPE and α-mangostin were comparably low to the leukemia cell lines (Figure 2) . MPE possessed the lowest IC 50 (2.79 µg/ml) toward K-562 whereas α-mangostin possessed the lowest IC 50 (1.12 µg/ml) to HL-60 (Table 5 ). The result of selectivity index showed that isotretinoin, a recent chemotherapy agent used to treat leukemia was less selective than MPE and α-mangostin toward HL-60, whilst imatinib was more selective toward K-562 than MPE and α-mangostin. Nevertheless, MPE and α-mangostin showed high selectivity toward both of HL-60 and K-562, with selectivity index was more than 3 (Table 5 ).
Data is presented as mean ± standard deviation, different lowercase of superscript letters in each row (Lymphocyte, K-562, HL-60) showed a significant difference at p < 0.05 (Tukey HSD post hoc test) among the concentrations, different uppercase of superscript letters in each column (100, 50, 25, 12.5, 6.25, 3.125) showed a significant difference at p < 0.05 (Tukey HSD post hoc test) among the cells. 
Discussion
The activities of xanthones and its derivates to inhibit certain molecular target in cancer progression are related to the tricyclic scaffold and its position 8 . As an anticancer, xanthones arrest cell cycle, induce apoptosis, and differentiation but inhibit the tumor cell proliferation, adhesion, invasion, and metastasis [16] [17] [18] . Xanthones were also reported to prevent initiation stage of cancer by inducing Quinine Reductase (QR) and inhibiting cytochrome P450 (CYP) activity 9, 19 . In this study, imatinib, isotretinoin, MPE, and α-mangostin showed a cytotoxic effect on the HL-60, K-562, and lymphocyte cells in a concentration-dependent manner. Microscopic images showed the cell density gradually decreased in the higher concentration of each treatment (Figure 1 ). This result was supported by the percentage of mortality data that showed the cell mortality increased in higher concentration of each treatment. Based on the Table 5 , the IC 50 value of MPE and α-mangostin toward HL-60 and K-562 cell lines was lower than the IC 50 value toward lymphocyte, with the selectivity index higher than 3. These findings suggested that MPE and α-mangosteen were safe against the normal lymphocyte, and possessed a high selectivity and sensitivity toward HL-60 and K-562 8, 15 . These results were consistent with Matsumoto et al. 22 study that showed the antiproliferative activity of xanthones in mangosteen pericarp against human leukemia 20 . The α-mangostin mediates mitochondrial apoptotic pathway in human promyelocytic leukemia (HL-60) by activating 21 . Together with β-mangostin, γ-mangostin, and methoxy-β-mangostin, these compounds arrest the cell cycle via expression of cyclin proteins in the human colon cancer cells (DLD-1) 11 . Furthermore, other anti-tumor activities of mangostins in several cancers have also been reported, including the inhibition of TCF/β-catenin transcription in colon cancer cells and inhibition of cell growth signaling pathways in chondrosarcoma 22 . These findings suggest that xanthones work by various pathways to cancer cells. In contrast, isotretinoin was either less selective or less sensitive toward the HL-60 cells compared with MPE and α-mangostin. Cancer has been known to be able to develop resistance towards chemotherapy. The resistance of leukemic cell lines to retinoic acid derivate might occur in molecular level by affecting several proteins functions and the mutations of the RARα receptor in APL can block the initiation of differentiation by retinoic acid 23 . On the contrary, Imatinib shows good sensitivity and selectivity toward K-562 human Chronic Myeloid Leukemia (CML) cells. CML is characterized by the presence of a Bcr-Abl fusion gene, which is caused by a reciprocal translocation of chromosomes 9 and 22 24 . The cytotoxic activity of imatinib was supported by other study, demonstrated that imatinib was able to inhibit Bcr-Abl kinase activity led to inactivate of survival pathways and induce long-term activation of caspases that responsible for the degradation and inactivation of Bcr-Abl tyrosine kinase as well as apoptosis of the K562 cells 25 .
Conclusion
Take together, our data suggest that MPE and α-mangostin possessed potent sensitivity and selectivity against leukemia. Both of them revealed higher selectivity and sensitivity than isotretinoin toward HL-60 cell line, while MPE also show high sensitivity and selectivity toward K-562 cell line, showing its great potential for pharmaceutical application. We suggest that MPE can be produced as a safe, efficient and low cost of an alternative remedy to fight leukemia. Therefore, the further study of mangosteen peel extract in molecular and in vivo study must be conducted.
